INTRODUCTION {#sec1-1}
============

Elevation of intraocular pressure (IOP) is an inherent and inadvertent association with the use of succinylcholine. The hemodynamic stress response of laryngoscopy and intubation results in an additional insult. Though many newer short-acting muscle relaxants have been introduced into the anesthetic practice, none of these agents could be projected as a replacement to succinylcholine in emergency situations. Hence, premedication with alpha~2~ agonists such as dexmedetomidine and clonidine which are known to reduce IOP\[[@ref1][@ref2]\] could help us to combat the ocular adverse effects of succinylcholine.

Aim of study {#sec2-1}
------------

The aim was to assess the efficacy of intravenous (IV) dexmedetomidine and clonidine premedication in attenuating rise in IOP during laryngoscopy and intubation following administration of succinylcholine.

SUBJECTS AND METHODS {#sec1-2}
====================

This prospective, observational study was conducted from January 2012 to December 2014. After obtaining Ethics Committee approval and patients' consent, 40 patients of both sexes, aged 20--60 years of American Society of Anesthesiologists (ASA) physical status I-II undergoing elective non-ophthalmic surgical procedures under general anesthesia requiring endotracheal intubation were recruited.

Patients with glaucoma, uncontrolled hypertension, congestive heart failure, renal or hepatic impairment, hyperthyroidism, difficult airway, those on antipsychotics and those with a history of hypersensitivity to the test drugs were excluded.

Following a detailed preanesthetic evaluation, patients were kept fasting for 6 h for solids and 2 h for clear fluids. Consecutive patients were allocated to either Group D or Group C. On day of surgery, in the operation theater, a 18 gauge IV cannula was put under local anesthesia and Ringer lactate solution was started for all the patients. Pre induction monitors like a pulse oximeter, non-invasive blood pressure monitor, and electrocardiogram were attached. Eyes of the patients were anesthetized with 4% topical lignocaine. For patients allocated in Group D, a bolus of dexmedetomidine 0.4 μg/kg body weight over 10 min was given. Patients in Group C received clonidine 1 μg/kg body weight over 10 min before induction.

All patients received a standardized anesthesia management and were induced with glycopyrrolate 0.2 mg, midazolam 2 mg, fentanyl 2 μg/kg, and propofol IV till loss response to verbal commands, following preoxygenation with 100% oxygen for 3 min. Laryngoscopy and intubation were attempted 1 min after administration of IV succinylcholine 2 mg/kg, meanwhile the patients were mask ventilated with 1% isoflurane in oxygen. After securing the airway with an appropriate sized endotracheal tube and after confirming the correct placement with end tidal carbon dioxide waveform and auscultation, vecuronium 0.1 mg/kg was given IV. Anesthesia was maintained with oxygen-nitrous oxide mixture (1:2) with isoflurane (1--1.5%) and intermittent muscle relaxants.

Intraocular pressure was measured with a Schiotz tonometer by an ophthalmologist just before and after test drug administration, immediately after induction, 45 s following administration of succinylcholine, then at 1 min, 3 min, 5 min, and 10 min after intubation. Heart rate (HR) and mean arterial blood pressure (MAP) were also documented at these time points. 30% reduction in systolic blood pressure was initially treated with an IV fluid bolus of 200 ml. If hypotension persisted, phenylephrine 50 μg was given IV, which was repeated if necessary.

Mann--Whitney test was used to compare the age, weight, HR, MAP, and IOP among groups, while Chi-square test was used to compare gender and ASA physical status. Wilcoxon test was used to compare the average IOP at different time points from the baseline in each group (intragroup analysis). The level of significance was taken as *P* \< 0.05.

RESULTS {#sec1-3}
=======

Comparison of the distribution of age, sex, weight, and ASA physical status of patients in both the groups were comparable \[*P* ≤ 0.05, [Table 1](#T1){ref-type="table"}\]. Baseline HR and that following premedication were comparable between the groups. However, comparison of HRs following induction, administration of succinylcholine, 1 min, 3 min, 5 min, and 10 min following intubation showed that the HR was significantly high in the Group C *P* ≤ 0.05, [Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}\].
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Baseline MAP was comparable in both groups. After premedication, there was a reduction in MAP in both the groups, which was significantly low in Group D (*P* = 0.021). However, following induction and succinylcholine both the groups had comparable MAP. At 1 min following intubation, there was an increase in MAP in both groups from the previous values, and Group C had a significantly higher MAP compared to Group D (*P* ≤ 0.001). At 3, 5, and 10 min, MAP started to decrease in both groups with Group C having significantly higher MAP at 3 and 5 min (*P* ≤ 0.001). At 10 min, MAP of both groups were comparable \[*P* = 0.050, [Table 3](#T3){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}\].
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Comparison of mean arterial pressures
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Intergroup analysis had shown that the mean baseline IOP of both Groups D and C were comparable (15.4 ± 2.6 vs. 14.7 ± 2.3, *P* = 0.277). Following premedication and induction, IOP decreased in both the groups and the reduction was significantly more in Group D (*P* ≤ 0.05). Following administration of succinylcholine and 1 min after intubation though there was an increase in IOP in both groups, the IOP still remained significantly low in Group D compared to Group C. There was gradual reduction in IOP in both groups at 3, 5, and 10 min and Group D continued to have a significantly low IOP than Group C up to 10 min \[[Table 4](#T4){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}\].
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Comparison of IOPs
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Intragroup analysis was done to find out the changes in IOP in each group from baseline values. Following premedication, Group D showed a significant reduction in IOP from baseline (15.4 ± 2.6) throughout the study period (*P* ≤ 0.05). Though there was an increase following succinylcholine and intubation, IOP never reached baseline values \[[Table 5](#T5){ref-type="table"}\]. Group C also showed a reduction in IOP following premedication and induction. However, following succinylcholine administration and intubation there was significant rise in IOP (16.0 ± 1.6 and 18.6 ± 2.2, respectively), which exceeded the baseline value (14.7 ± 2.3). By 10 min, IOP normalized and was comparable with the baseline value \[[Table 6](#T6){ref-type="table"}\].
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Comparison of baseline IOP with subsequent IOP in Group D
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Comparison of baseline IOP with subsequent IOP in Group C
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DISCUSSION {#sec1-4}
==========

The IOP reflects the tissue pressure of the intraocular contents and the normal range is 10--20 mm Hg. An acute increase in IOP may cause expulsion of the global contents through an open globe injury or surgical incision. It can also lead to retinal artery occlusion and retinal ischemia. Chronic increase in IOP ultimately results in ischemic optic neuropathy either due to a direct effect or because of chronic underperfusion of the nerve.\[[@ref3]\] Perioperative visual loss is a catastrophic event which can follow non ophthalmic surgery, especially cardiac and spine surgery, and the most common causes are retinal vascular occlusion and ischemic optic neuropathy.\[[@ref4]\]

Rise in IOP during anesthesia is often overlooked during non ophthalmic surgery. A certain degree of increase in IOP is inevitable during the regular conduct of general anesthesia. The common causes of rise in IOP under anesthesia include hypertension, hypercarbia, hypoxia, head low position, expansion of the intravascular volume, undue flexion of neck leading to venous congestion, external pressure on eyeball, use of atropine, in patients with narrow angle glaucoma, and succinylcholine.

In emergency situations and during difficult intubation, succinylcholine is considered as the most useful muscle relaxant to aid laryngoscopy and intubation because of its faster onset of action and excellent skeletal muscle relaxation properties. Use of succinylcholine in ocular trauma is controversial as it leads to an increase in IOP of up to 10 mm Hg which lasts for 10 min.\[[@ref3]\] Hence, in the presence of an open globe injury succinylcholine can result in expulsion of the contents of the eyeball. Though in normal patients the increase in IOP following succinylcholine may not increase IOP sufficient enough to cause permanent damage, in those with an already high IOP the outcome can be devastating.

Securing the airway with a cuffed endotracheal tube necessitates instrumentation of the airway. The hemodynamic stress response that accompany laryngoscopy and intubation can increase IOP by 10--20 mm Hg.\[[@ref3]\] Among the various pharmacological measures adopted to blunt the hemodynamic stress response that accompany laryngoscopy and intubation, administration of dexmedetomidine prior to induction of general anesthesia has shown promising results.\[[@ref5][@ref6][@ref7]\] This alpha~2~ agonist has shown to produce anxiolysis, sedation, sympatholysis, and analgesia. Secondary to the alpha~2~ mediated decrease in sympathetic tone, it blunts the hemodynamic responses of intubation, surgery, and extubation. It has approximately 7--8 times alpha~2~ selectivity than that of clonidine.\[[@ref8]\]

Another advantage of dexmedetomidine is its ability to reduce IOP.\[[@ref9]\] There are many mechanisms by which dexmedetomidine reduces IOP. By its direct vasoconstrictor effect on the afferent blood vessels of the ciliary body, it reduces aqueous humor production. It facilitates the drainage of aqueous humor by reducing sympathetically mediated vasomotor tone of the ocular drainage system.\[[@ref10]\] In addition, the hypotension that follow dexmedetomidine administration can also result in a reduced IOP.

Dexmedetomidine in doses like 0.4 μg/kg body weight and 0.6 μg/kg body weight given IV as premedication were found to be effective in preventing the rise of IOP associated with administration of succinylcholine and endotracheal intubation. But dexmedetomidine 0.4 μg/kg was recommended for this purpose as this dose did not result in significant hypotension.\[[@ref11]\] But another study has shown that even 0.6 μg/kg given IV over 10 min, 10 min before induction, effectively prevented the rise in IOP associated with suxamethonium, laryngoscopy, and intubation with stable hemodynamics.\[[@ref12]\]

Following succinylcholine and intubation, even if the patient is premedicated with dexmedetomidine 0.6 μg/kg, IOP increases, but the IOP rise is not significantly different from the baseline value. Based on these observations, dexmedetomidine is now recommended as a beneficial premedication in open globe injuries.\[[@ref13]\] The drug was found to reduce the IOP by 34% after a single IV dose of 0.6 μg/kg\[[@ref14]\] Higher doses of dexmedetomidine \>0.6 μg/kg is associated with an additional reduction in the arterial pressure and HR without any further decrease in the IOP.\[[@ref15][@ref16]\]

Clonidine, another alpha~2~ agonist, also decreases IOP following systemic\[[@ref1][@ref17]\] as well as topical administration.\[[@ref18]\] It causes an increase in vascular resistance and thereby reduces retinal blood flow. Oral clonidine 300 μg premedication can prevent the increase in IOP following succinylcholine administration.\[[@ref19]\] However, conflicting results were reported following its IV use. Tripathi *et al*., reported that clonidine given at a dose of 1 μg/kg IV did not attenuate hemodynamic stress response to intubation and extubation. However, clonidine 2 μg/kg prevented hemodynamic stress response to intubation and extubation.\[[@ref20]\]

Another study showed that the IV clonidine in doses of 1 μg/kg and 2 μg/kg administered 10 min prior to induction significantly attenuated the stress response to laryngoscopy and intubation. While clonidine 2 μg/kg resulted in hypotension at the time of induction and postoperative sedation, it was not observed with clonidine 1 μg/kg. Hence, a single IV low-dose clonidine 1 μg/kg combined with fentanyl 2 μg/kg was suggested as a safe and effective method with minimal side effects to attenuate the hemodynamic stress response to laryngoscopy and intubation.\[[@ref21]\] However, clonidine even at a dose of 2 μg/kg IV did not seem to have any effect in IOP just before and just after intubation.\[[@ref22]\]

A recently published study comparing the effect of the IV clonidine and dexmedetomidine on IOP had shown that clonidine 2 μg/kg attenuated rise in IOP following succinylcholine, but not that following laryngoscopy and intubation. But dexmedetomidine 0.5 μg/kg was effective in this regard.\[[@ref23]\] The main differences of this study from ours being in the dose of dexmedetomidine and clonidine used. We used dexmedetomidine 0.4 μg/kg and obtained similar results. A reduction in the dose may ensure hemodynamic stability and an improved margin of safety. In our study, clonidine 1 μg/kg only was used, which did not prevent the rise in IOP after succinylcholine, laryngoscopy or intubation. We did not use a higher dose for fear of causing prolonged intraoperative hypotension.

One of the drawbacks of our study was that the only option available for us to measure IOP was by using Schiotz tonometry. This is an indentation tonometer which determines IOP by measuring how much cornea is indented by a given weight. The indentation tonometry is considered less accurate as it doesn't take into account corneal thickness and viscoelasticity. However, in patients with no significant corneal disease and in the absence of corneal edema, this technique provides IOP values with reasonable accuracy. Moreover, Schiotz tonometers are commonly available and easy to use.

The accuracy of IOP measurement depends on the circadian variation,\[[@ref24]\] corneal thickness, curvature, and biomechanical properties.\[[@ref25][@ref26][@ref27][@ref28]\] Goldmann applanation tonometry is taken nowadays as the gold standard and is more precise in patients having an average central corneal thickness of between 500 and 525 μm. Dynamic contour tonometry and ocular response analyzer seem to be largely independent of the corneal biomechanical properties and may be particularly helpful in eyes with corneal abnormalities. However, among all tonometers, none is highly accurate when both corneal thickness and surface irregularities are present.\[[@ref29]\]

CONCLUSION {#sec1-5}
==========

Dexmedetomidine 0.4 μg/kg premedication resulted in a reduction of IOP and effectively blunted the increase in IOP, which followed administration of succinylcholine, laryngoscopy, and intubation. Though clonidine 1 μg/kg reduced IOP, it did not prevent rise in IOP following succinylcholine, laryngoscopy, and intubation. Both dexmedetomidine and clonidine effectively attenuated hemodynamic responses to laryngoscopy and intubation.
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